Isolated longitudinal myelitis: A report of six cases

Spinal Cord

Volumn 47, Issue 3, 2009, Pages 257-261

  Pawate, S ^a   Sriram, S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Longitudinal myelitis; Neuromyelitis optica; Rituximab

Indexed keywords

AZATHIOPRINE; INTERFERON BETA SERINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADULT; ARTICLE; BLADDER FUNCTION; BRAIN; BRAIN ISCHEMIA; CERVICAL SPINE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTRAST ENHANCEMENT; CONUS MEDULLARIS; CONVALESCENCE; FEMALE; HEALTH CENTER; HUMAN; IMAGING; INTESTINE FUNCTION; LABORATORY; MALE; MEDICAL RECORD REVIEW; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OUTPATIENT; OUTPATIENT DEPARTMENT; PLASMAPHERESIS; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SENSORY SYSTEM; SPINAL CORD; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVERSITY HOSPITAL;

ADULT; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELITIS; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SPINAL CORD; YOUNG ADULT;

EID: 62049086089     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2008.99     Document Type: Article

References (13)

1. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002; 59: 499-505.
2. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006; 59: 566-569.
3. Deodhar AA, Hochenedel T, Bennett RM. Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis. J Rheumatol 1999; 26: 446-449.
4. Tellez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, Davila-Maldonado L. Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. Lupus 2001; 10: 851-856.
5. Lehnhardt FG, Impekoven P, Rubbert A, Burghaus L, Neveling M, Heiss WD et al. Recurrent longitudinal myelitis as primary manifestation of SLE. Neurology 2004; 63: 1976.
6. Chen HC, Lai JH, Juan CJ, Kuo SY, Chen CH, Chang DM. Longitudinal myelitis as an initial manifestation of systemic lupus erythematosus. Am J Med Sci 2004; 327: 105-108.
7. Orzechowski NM, Michet Jr CJ. Longitudinal myelitis. Mayo Clin Proc 2008; 83: 350.
8. Heinlein AC, Gertner E. Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus. Lupus 2007; 16: 823-826.
9. Doan T, Massarotti E. Rituximab. Drugs Today (Barc) 2005; 41: 785-797.
10. Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Opin Neurol 2007; 20: 255-260.
11. Wingerchuk DM, Weinshenker BG. Neuromyelitis Optica. Curr Treat Options Neurol 2005; 7: 173-182.
12. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125 (Part 7): 1450-1461.
13. Lennon VA, Wingerchuk DM, Kryzer TJ. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.